![]() ![]() In conjunction with the administration’s announcement of the May 11 termination of the PHE, various regulatory agencies issued guidance with respect to the termination concurrent with the end of the PHE, sunsetting at some point after the end of the PHE, or continuation of these regulatory flexibilities. The HHS Office for Civil Rights (OCR) similarly announced HIPAA enforcement discretion waivers.Īdditionally, the Centers for Medicare & Medicaid Services (CMS) addressed impediments to the delivery of patient care by providing an array of waivers and flexibilities to help alleviate administrative burdens. The HHS Office of Inspector General (OIG) announced that it would exercise enforcement discretion with respect to certain administrative enforcement authorities to provide flexibility and minimize burdens for the healthcare industry as it faced the challenges of the pandemic that, among other things, increased the availability and coverage of telehealth services. With the PHE coming to an end, organizations may need to make drastic changes as the regulatory enforcement returns to “normal.”įor example, the US Food and Drug Administration (FDA) granted emergency use authorizations to certain medical (particularly COVID-19 testing) devices to support the nation’s response to the pandemic. The PHE declaration, which first was issued by the Secretary of the US Department of Health and Human Services (HHS) on January 31, 2020, and subsequently renewed several times, provided the basis for numerous flexibilities upon which the healthcare and life sciences industries have relied to furnish patient care during the pandemic. ![]() The Biden administration announced on Januthat the COVID-19 Public Health Emergency (PHE) would officially end on May 11, 2023. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |